Matteo Staderini was born in Ascoli Piceno (Italy) in 1984. He received his degree in Chemistry and Pharmaceutical Technologies in 2009 from the University of Bologna. He then moved to Madrid (Spain) where he gained an Interuniversity Masters degree in Medicinal Chemistry (2010) from Complutense, Alcala´ and CEU San Pablo Universities. In 2011 he awarded a four-year fellowship from the University Complutense of Madrid and started his PhD under the joint supervision of Prof. José Carlos Menéndez and Prof. Maria Laura Bolognesi at the Department of Organic and Pharmaceutical Chemistry. He was involved in a drug discovery program aimed to the design and synthesis of small molecules as fluorescent probes for the investigation of biological processes or as drug candidates for neurodegenerative diseases. In particular, he focused his research efforts on the identification of theranostic small molecules as innovative therapeutic tools. During his doctoral studies, he had also the opportunity to spend a period abroad at the University of East Anglia in Norwich, where he carried out the synthesis of targeted nanocarriers for the treatment of metastatic melanoma. In March 2015 he received his PhD degree and after a few months joined the Prof. Mark Bradley’s research group as a postdoctoral researcher, where he is currently involved in the IMPACT project working on the development of chemical probes for implantable microsystems for personalised anti-cancer therapy.
In his spare time Matteo enjoys rock climbing, cooking, travelling and going out with friends.